Stockholm-based Biolin Scientific Holding signs licensing agreement with Munich spin-out Nanion.
Nanion Technologies, a life sciences spin-out of Munich University, has signed a licensing agreement with Biolin Scientific Holding, a Sweden-based instrumentation company.
The deal, which was for an undisclosed fee, will allow Biolin access to Nanion’s patents. Founded in 2002, Nanion has been commercialising cell analysis technologies which provide high quality data through the use of multiple sets of ion channel screening.
Johan von Heijne, president and CEO of Biolin Scientific, said: “This deal affirms our commitment to invest in…